Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-545-4 | CAS number: 7631-86-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The dataset for covering the endpoint in vitro genotoxicity of untreated (hydrophilic) SAS compiles 9 studies performed with different hydrophilic forms of the substance and BET values ranging from 30 to 420 m²/g. Several different test methods were used, and all studies meet the criteria of Klimisch score 1 or 2.
5 Bacterial reverse mutation assays were carried out, all under GLP, according to OECD TG 471 or similar protocols, both with and without metabolic activation. All these studies were negative.
Using mammalian cells, 2 chromosome aberration assays were carried out according to OECD TG 473 or similar protocols, both with and without metabolic activation and one under GLP. All results were negative.
One Gene mutation testing on mammalian cells was carried out according to EPA OPP 84-2 under GLP. No positive effects were detected in this study.
One additional test for Unscheduled DNA Synthesis (UDS) carried out, under GLP, with rat primary hepatocytes according to OECD TG 482 yielded negative results.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Nov. 20-27, 1989
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 84-2
- Principles of method if other than guideline:
- 8 dose l., 5h duration, w & w/o S9-activation, 7d post obs.
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell gene mutation test using the Hprt and xprt genes
- Specific details on test material used for the study:
- synthetic amorphous silicon dioxide CAB-O-SIL EH-5
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- CHO-K1-BH4 cells were obtained directly from Dr. Abraham Hsie, Oak Ridge National Laboratories, Oak Ridge, TN, USA. The freeze lot of cells was tested and found to be free of mycoplasma using both the agar culture and Hoechst stainibg procedures.
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix.
- Test concentrations with justification for top dose:
- 50, 100, 150 ,200, 250, 300, 400, 500 µg/ml
- Vehicle / solvent:
- The treatment medium consisted of 4 ml F12FBS5-Hx containing various concentrations of test article and 1 ml S-9 reaction mixture for the activated study and 5 ml F12FBS5-Hx containing various concentrations of test article for the non-activated study. The final solvent concentration in the culture medium was 1% by volume.
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- ethylmethanesulphonate
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- The cytotoxic effects (concurrent cytototoxicity) of a 5 hour treatment of CHO cells in the presence ad absence of an exogenous metabolic activation system are presented in Table 2. Mutagenicity data are presented in Tables 3 and 4.
- Conclusions:
- synthetic amorphous silicon dioxide Cab-O-Sil EH-5 was negative in the CHO/HGPRT mutation assay both with and without metabolic activation.
- Executive summary:
synthetic amorphous silicon dioxide CAB-O-SIL EH-5C was tested according to EPA guideline OPP 84 -2 under GLP conditions
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- surface treated synthetic amorphous silicon dioxide RA200HS
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- S-9 mix obtained from Aroclor 1254 treated male Sprague-Dawley rats' livers.
- Test concentrations with justification for top dose:
- 50, 150, 500, 1500, 5000 µg/plate
up to maximum recommended dose level - Vehicle / solvent:
- ethanol
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- N-ethyl-N-nitro-N-nitrosoguanidine
- other: Aminoanthracene
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- No significant increase in the frequency of revertant colonies was recorded for any of the bacterial strains with any dose of the test material either with or without metabolic activation.
- Conclusions:
- surface treated synthetic amorphous silicon dioxide RA200HS was not mutagenic under the test conditions
- Executive summary:
An Ames test in S. typhimurium and E coli was conducted with surface treated synthetic amorphous silicon dioxide RA200HS.
- Endpoint:
- in vitro DNA damage and/or repair study
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- Nov. 28 - Dec. 22, 1989
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5550 - Unscheduled DNA Synthesis in Mammalian Cells in Culture
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 84-2
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- other: UDS assay
- Specific details on test material used for the study:
- synthetic amorphous silicon dioxide CAB-O-SIL EH-5
- Species / strain / cell type:
- hepatocytes:
- Details on mammalian cell type (if applicable):
- primary rat hepatocytes derived from the livers of normal adult male Fischer 344 rats
- Metabolic activation:
- without
- Test concentrations with justification for top dose:
- 0.3, 1.0, 3, 10, 30, 100, 300, 1000 µg/ml
- Vehicle / solvent:
- DMSO
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- Details on test system and experimental conditions:
- treated for 18-20 hrs
- Key result
- Species / strain:
- hepatocytes:
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- synthetic amorphous silicon dioxide Cab-O-Sil EH-5 did not cause any significant increase in unscheduled DNA synthesis as measured by the mean number of net nuclear grain counts, at any dose level.
cf. tables 2 & 3 for more details on results - Conclusions:
- synthetic amorphous silicon dioxide Cab-O-Sil EH-5 was negative in the UDS assay under the test conditions,
- Executive summary:
An unschedulded DNA synthesis assay was conducted with synthetic amorphous silicon dioxide Cab-O-Sil EH-5 in rat primary hepatocyte cells.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- Dec. 1, 1989 - Feb. 20, 1990
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 84-2
- Principles of method if other than guideline:
- (9 dose l., 15-18h duration, w & w/o S9-activation)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
- Specific details on test material used for the study:
- synthetic amorphous silicon dioxide Cab-O-Sil EH-5
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix.
- Test concentrations with justification for top dose:
- non-activated: 19, 38, 75, 150, 300 µg/ml
activated: 250, 500, 750, 1000 µg/ml - Vehicle / solvent:
- DMSO
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- triethylenemelamine
- cyclophosphamide
- Details on test system and experimental conditions:
- Cells were collected for evaluation at 18 or 15 hours after treatment in the non-achtivated or S-9 activated system, respectively
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- cf. tables 3 & 4 for more details
- Conclusions:
- synthetic amorphous silicon dioxide Cab-O-Sil EH-5 was negative in the CHO cytogenetics assay.
- Executive summary:
synthetic amorphous silicon dioxide Cab-O-Sil EH-5 was tested in a chromosome aberration test using Chinese hamster ovary cells.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- Nov. 20 - Dec. 28, 1989
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 84-2
- Deviations:
- yes
- Remarks:
- vehicle control in TA100 strain test
- Principles of method if other than guideline:
- Ames test in salmonella, w & w/o S9-activation
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- synthetic amorphous silicon dioxide Cab-O-Sil EH-5
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix
- Test concentrations with justification for top dose:
- 667, 1000, 3333, 6667, 10000 µg/plate
- Vehicle / solvent:
- DMSO
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- sodium azide
- other: 2-aminoanthracene, ICR-191
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Vehicle controls validity:
- not valid
- Remarks:
- however vehicle control plated with another study on the same day was acceptable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- synthetic amorphous silicon dioxide was not mutagenic tunder the test conditions
- Executive summary:
An Ames test was conducted with synthetic amorphous silicon dioxide Cab-O-Sil EH-5.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- yes
- Remarks:
- without external metabolic activation system
- Principles of method if other than guideline:
- Method: Culture technique, determination of cytotoxicity and test for chromosomal aberrations decribed and similar to current guideline (OECD 473)
- GLP compliance:
- no
- Type of assay:
- in vitro mammalian chromosome aberration test
- Specific details on test material used for the study:
- synthetic amorphous silicon dioxide Syloid 244
- Species / strain / cell type:
- other: Human embryonic lung cells (WI-38)
- Metabolic activation:
- without
- Test concentrations with justification for top dose:
- 0.1, 1.0, and 10 µg/ml (note: mcg/ml is stated: Tab. Test I, p. 83)
Dose selection: 10 µg/ml was the highest level free of observable cell clumping (see Report p. 6/7). - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: water, 0.85 % saline
- Justification for choice of solvent/vehicle: suspension - Negative solvent / vehicle controls:
- yes
- Remarks:
- saline
- Positive controls:
- yes
- Positive control substance:
- triethylenemelamine
- Remarks:
- Migrated to IUCLID6: 0.1 µg/ml
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in suspension, 5 x10^5 cells/mL
Mutations were quantified by counting anaphase aberrations.
DURATION
- Incubation temperature: 37 °C
- Exposure duration: 24 - 48 h
Fixation: absolute methanol:glacial acetic acid (3:1) for 30 min after centrifugation
STAIN (for cytogenetic assays): acetic acid-orcein stain (2.0 %)
NUMBER OF REPLICATIONS: 3/dose level
NUMBER OF CELLS EVALUATED: 100/dose level
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index; other: "any cytopathic effect" at 24, 48, and 72 h after exposure to dose levels logarithmatically spaced
OTHER EXAMINATIONS:
- Determination of polyploidy: yes - Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Remarks:
- "clumping" of cells as criterion for maximum dose selection
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Conclusions:
- synthetic amorphous silicon dioxide Syloid 244 was negative in human embryonic lung cells
- Executive summary:
The genetic toxicity potential of synthetic amorphous silicon dioxide Syloid 244 was studied in human embryonic lung cells (WI-38).
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- Jul. 12 - Oct. 31, 1978
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Ames test in salmonella, w & w/o S9-activation
- GLP compliance:
- no
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- synthetic amorphous silicon dioxide Cab-O-Sil M5
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Metabolic activation system:
- not specified
- Test concentrations with justification for top dose:
- 5 mg
- Vehicle / solvent:
- DMSO
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- methylmethanesulfonate
- other: 2-aminofluorene
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- cf. illustration below for details
- Conclusions:
- synthetic amorphous silicon dioxide Cab-O-Sil M5 did not cause a positive response with any of the tester strains in the presence or absence of Aroclor-induced rat liver S9.
- Executive summary:
An Ames test in five salmonella strains was conducted with synthetic amorphous silicon dioxide Cab-O-Sil M5.
Referenceopen allclose all
Anaphase aberrations (from Report Table p. 83)
Mitotic index1) |
No. of cells |
% cells with acentric frag. |
% cells with bridges |
% multipolar cells |
% cells other aberr.2) |
% cells with aberr. |
|
Syloid |
|||||||
0.1 µg/mL |
3 |
100 |
3 |
0 |
0 |
0 |
3 |
1.0 µg/mL |
4 |
100 |
4 |
1 |
0 |
0 |
5 |
10.0 µg/mL |
4 |
100 |
0 |
0 |
0 |
0 |
0 |
Saline |
3 |
100 |
1 |
0 |
0 |
0 |
1 |
TEM (0.1 µg/mL) |
2 |
100 |
13 |
4 |
1 |
3 (pp) |
21 |
1) % cells in mitosis: 200 cells observed/dose level
2) Cells with polyploidy, pulverisation (pp), or greater than 10 aberrations
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
The in vivo genotoxicity potential of untreated (hydrophilic) SAS was evaluated in 3 studies launched from 1974 to 2000 with materials having BET range from 175 to 349 m²/g. All these studies meet the criteria of Klimisch score 2.
A rodent dominant lethal test (similar to OECD guideline 478), was performed in 1974 on the substance and no mutagenic potential was detected.
A Mammalian bone marrow chromosome aberration was performed according to OECD 475 and no genotoxicity was detected. No genotoxic effects in alveolar epithelial cells occurred in an ex-vivo/in-vitro HPRT assay.
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test)
- GLP compliance:
- no
- Type of assay:
- chromosome aberration assay
- Specific details on test material used for the study:
- synthetic amorphous silicon dioxide Syloid 244
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Route of administration:
- oral: gavage
- Vehicle:
- - vehicle: 0.85 % saline
- Volume of the vehicle: no data
- Justification for choice of solvent/vehicle: no data
- Concentration of test material in vehicle: no data
MAXIMUM DOSE VOLUME APPLIED: no data - Details on exposure:
- 3 time points: sampling at 6, 24, and 48 h in the single-dose study
1 time point: sampling at 6 h after the last dose in the repeated-dose study
Colcemide (4 mg/kg bw i.p) was given 2 h prior to kill. - Duration of treatment / exposure:
- single administration (acute) and repeated administration (5 times, subacute)
- Frequency of treatment:
- 1x, and 5x(1x/d)
- Dose / conc.:
- 1.4 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 14 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 140 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 500 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 5 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 5; but 3 as vehicle control
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- triethylenemelamine
- Route of administration: i.p.
- Doses / concentrations: 0.3 mg/kg bw - Tissues and cell types examined:
- bone-marrow cells
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- not specified
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- synthetic amorphous silicon dioxide Syloid 244 was negativein in in vivo chromosome aberration test.
- Executive summary:
An in vivo chromosome aberration test similar to OECD 475 was conducted with synthetic amorphous silicon dioxide Syloid 244
- Endpoint:
- in vivo mammalian germ cell study: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: well documented research study
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Method: ex-vivo/in-vitro HPRT mutation assay, no standard guideline available.
- GLP compliance:
- not specified
- Type of assay:
- other: mammalian cell gene mutation assay: ex-vivo/in-vitro HPRT assay
- Specific details on test material used for the study:
- synthetic amorphous silicon dioxide AEROSIL 200
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Weight at study initiation: 200 - 250 g
- Route of administration:
- inhalation
- Details on exposure:
- TYPE OF INHALATION EXPOSURE: whole body
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: 300-L horizontal laminar-flow chamber, compartmentalised
- System of generating particulates/aerosols: srew-feed mechnaism (ACCURate, Whitewater) in combination with a Venturi-type dust feeder
- Temperature, humidity, pressure in air chamber: no data
- Air flow rate: no data
- Air change rate: no data
- Method of particle size determination: no data
- Duration of treatment / exposure:
- 13 wks
- Frequency of treatment:
- 6 h/d, 5 d/wk
- Post exposure period:
- 3 and 8 months
- Dose / conc.:
- 50.4 mg/m³ air (analytical)
- Remarks:
- 50.4 +/- 19-0 mg/m³
- No. of animals per sex per dose:
- no data, only males, probably 4 animals per endpoint
- Control animals:
- yes, sham-exposed
- Positive control(s):
- Crystalline silica was examined simulataneously and showed genotoxic effects in alveolar epithelial cells.
- Tissues and cell types examined:
- The testing programme included cellular and biochemical Bronchoalveolar Lavage Fluid Analysis (BLA) on inflammatory markers, histopathology, inflammatory cytokine gene expression, immunohistochemisty for DNA damage, and mutagenesis in alveolar epithelial cells.
- Statistics:
- Analysis of variance, Dunnett´s test for determination of differences between control and treated groups.
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Remarks:
- Alveolar type-II cells isolated from the 50-mg/m3 rat group showed no increased mutation frequency as compared to the control.
- Toxicity:
- yes
- Remarks:
- inflammation; but inflammation is not responsible for the development of mutagenic effects in rat lungs alter high doses of particle exposures
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- Despite a high degree of infammatory-cell response, no genotoxic effects in alveolar epithelial cells occurred after exposure of synthetic amorphous silicon dioxide AEROSIL 200
- Executive summary:
This is the main part of a comparative study including synthetic amorphous and crystalline silica. Here only the mutagenic effects of Aerosil 200 (amorphous) are documented.
- Endpoint:
- in vivo mammalian germ cell study: cytogenicity / chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 478 (Genetic Toxicology: Rodent Dominant Lethal Test)
- GLP compliance:
- no
- Type of assay:
- rodent dominant lethal assay
- Specific details on test material used for the study:
- synthetic amorphous silicon dioxide Syloid 244
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Vehicle:
- - vehicle: 0.85 % saline
- Volume of the vehicle: no data
- Justification for choice of solvent/vehicle: no data
- Concentration of test material in vehicle: no data
MAXIMUM DOSE VOLUME APPLIED: no data - Duration of treatment / exposure:
- single administration (acute) and repeated administration (5 times, subacute)
- Frequency of treatment:
- 5x (1x/day)
- Remarks:
- Doses / Concentrations:
1.4, 14.0, 140, 500 and 5000 mg/kg suspended in 0.85 % saline
Basis: - Dose / conc.:
- 1.4 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 14 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 140 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 500 mg/kg bw/day (nominal)
- Dose / conc.:
- 5 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 10 males (treated) mated to virgin female rats (2 females/1 male)
- Control animals:
- yes, concurrent vehicle
- yes, historical
- Positive control(s):
- triethylene melamine
- Route of administration: i.p.
- Doses / concentrations: 0.3 mg/kg bw - Sex:
- male/female
- Genotoxicity:
- negative
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- synthetic amorphous silicon dioxide Syloid 244 was not mutagenic
- Executive summary:
A dominant lethal assay study was conducted with synthetic amorphous silicon dioxide Syloid 244 in rats to assess its mutagenic potential.
- Endpoint:
- genetic toxicity in vivo, other
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
- Justification for type of information:
- a gene mutation in mammalian cells and a study with rat primary hepatocytes both yielded negative results.
Referenceopen allclose all
After 13 weeks of exposure, lavage neutrophils were increased from 0.26% (controls) to 55% of total lavaged cells for amorphous silica, with significantly greater lavage neutrophil numbers. BAL fluid levels of LDH as an indicator of cytotoxicity were high for amorphous silica, at the end of exposure. All parameters decreased rapidly for amorphous silica in the 8-month recovery period. Increased MIP-2 expression was observed at the end of the exposure period for amorphous silica. After 8 months of recovery, those markers were not significantly different from controls. No significant increase in HPRT mutation frequency in alveolar epithelial cells was detected after 13 weeks of exposure to amorphous silica. A significant, increase in TUNEL staining was detected in macrophages and terminal bronchiolar epithelial cells of amorphous silica-exposed rats at the end of the exposure period. However, no genotoxic effects in alveolar epithelial cells occurred after amorphous silica exposure, despite a high degree of infammatory-cell response.
Acute: Some changes were observed in the low and mid dose
group. In the high dose (5000 mg/kg bw), no significant changes
were seen.
Subacute: In the intermittent dose groups of test series I
significant decreases were seen in fertility index and number of
implants in week 5 (Report Tab. I, p. 100).
Dose related decreases were observed in corpora lutea
(week 5) and dead implants/pregnant female in week 4. Dose
related increases were seen in corpora lutea (week 3),
preimplantation loss (week 2, 3)(Report, Tab. II - VIII, p.101 -107).
But no consistently significant effects were noted at the two highest
doses (500 and 5000 mg/kg bw) in test series II.
A time trend pattern was not found either.
The positive control(triethylene melamine) administered as a single
i.p. dose to males produced a slight decrease in mean number of
implantations per litter (wk 1 - 3) [Report, Tab. II, p. 93] and
significant increases in dead implants and in preimplantation losses
from post-treatment week 1 through 4 (Report,"acute study", Tab. II -
VIII, p. 93 -99] without affecting the fertility index (Report, Tab. I,
p.92).
--------------
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for classification or non-classification
Available studies did not identify any potential towards genotoxicity. According to Annex I of the Regulation (EC) 1272/2008 (table 3.5.1) and GHS (Globally Harmonized Classification System), the test substance requires no classification and has no mandatory label requirement.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.